The Amvuttra Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Amvuttra Market has shown a high compound annual growth rate (HCAGR) of XX% in recent years. The market increased from a value of $XX million in 2024 to an estimated $XX million in 2025.
The Amvuttra market is projected to expand to $XX million by the year 2029, growing at a compound annual growth rate (CAGR) of XX%.
Download Your Free Sample of the 2025 Amvuttra Market Report and Uncover Key Trends Now!Key growth drivers of the amvuttra market include:
• Growing prevalence of hemophilia is fueling market growth
• Improved diagnostic methods and advancements in treatments
• Better detection rates, leading to early and more effective intervention
• The use of Altuviiio in hemophilia A for more effective bleeding control and reduced dosage frequency
The amvuttra market covered in this report is segmented –
1) By Indication: Hereditary Transthyretin-Mediated Amyloidosis (Adult Polyneuropathy, Cardiomyopathy)
2) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Online Pharmacies
3) By End-User: Adult, Geriatric
Market trends in the amvuttra market include:
• The development of long-acting injectable formulas is an emerging trend in the market.
• Personalized and genetic therapies are increasingly gaining traction.
• Research and development activities are on the rise in the market.
• Advancements in telemedicine is another key trend shaping the future of the market.
The top competitors and leading players in the amvuttra market are:
• encompass Swedish Orphan Biovitrum.
North America was the largest region in the amvuttra market in 2024